Private Placement - Additional Information (Details)						2 Months Ended	3 Months Ended		9 Months Ended
	Sep. 29, 2024 USD ($) $ / shares shares	Apr. 18, 2024 USD ($) $ / shares shares	Dec. 26, 2023 USD ($) d $ / shares shares	Sep. 29, 2023 USD ($)	Sep. 28, 2023 USD ($) shares	Feb. 29, 2024 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) shares	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) shares	Sep. 30, 2023 USD ($)	Dec. 25, 2023 USD ($)
Derivative [Line Items]
Shares purchased (in shares) | shares					3,168,121
Consideration received				$ 32,900,000	$ 32,900,000
Anniversary of closing period					1 year
Minimum escrow releasement					$ 0
Approaches or exceeds, threshold trigger (in USD per share) | $ / shares	$ 10.44
Decreases below, threshold trigger (in USD per share) | $ / shares	10.44
Change in share price (in USD per share) | $ / shares	$ 2.00
Shortfall, consideration received on transaction	$ 100,000
Loss on issuance of forward purchase				24,500,000					$ 17,876,000	$ 24,475,000
Derivative liabilities				20,200,000
Bonus stock				$ 4,300,000
Anniversary term				1 year
Loss on amendments to financial instruments, net									3,940,000	0
Reduction in forward purchase derivative liabilities			$ 14,200,000
Subscription receivable		$ 300,000
Loss on derivative		$ 300,000					$ (16,849,000)	$ (1,741,000)	(31,004,000)	$ 1,043,000
Bonus Shares
Derivative [Line Items]
Shares purchased (in shares) | shares	514,889
December 2023 FPA Amendment
Derivative [Line Items]
Consideration received			$ 500,000
Approaches or exceeds, threshold trigger (in USD per share) | $ / shares			$ 10.44
Number of shares re-designated (in shares) | shares			200,000
Discount of VWAP measurement			0.100
Derivative liability, additional share issuance of VWAP			0.900
VWAP trading days | d			20
Sale of stock, common stock purchase agreement, prepayment shortfall increase available			$ 500,000
Pre-existing prepayment shortfall											$ 100,000
Loss on amendments to financial instruments, net			442,000
Reduction of subscription receivable			$ 15,123,000
Number of additional shares available (in shares) | shares			200,000
Reduction in forward purchase derivative liabilities			$ (14,181,000)
Q1 2024 FPA Amendments
Derivative [Line Items]
Consideration received						$ 1,000,000.0
Decreases below, threshold trigger (in USD per share) | $ / shares						$ 10.44
Discount of VWAP measurement						0.100
Sale of stock, common stock purchase agreement, prepayment shortfall increase available						$ 1,100,000
Pre-existing prepayment shortfall						700,000
Loss on amendments to financial instruments, net						396,000
Reduction of subscription receivable						$ 2,764,000
Number of additional shares available (in shares) | shares						200,000
Reduction in forward purchase derivative liabilities						$ (1,418,000)
Forward Purchase Contract Amendments
Derivative [Line Items]
Shares purchased (in shares) | shares		248,360
Initial price ceiling (in usd per share) | $ / shares		$ 1.27
Q3 2024 FPA Amendments
Derivative [Line Items]
Shares purchased (in shares) | shares							248,360
Consideration received							$ 1,200,000
Sale of stock, common stock purchase agreement, prepayment shortfall increase available							1,400,000
Pre-existing prepayment shortfall							100,000		100,000
Loss on amendments to financial instruments, net							(1,670,000)
Reduction of subscription receivable							$ 10,389,000
Number of additional shares available (in shares) | shares							950,000
Reduction in forward purchase derivative liabilities							$ (10,897,000)
New Forward Purchase Contract, Q3 2024 FPA Amendments
Derivative [Line Items]
Shares purchased (in shares) | shares							1,216,350
Subscription receivable							$ 300,000		$ 300,000
Loss on derivative							$ 400,000
2024 FPA Amendments | FPA Investor
Derivative [Line Items]
Shares purchased (in shares) | shares									2,497,854
Private Placement
Derivative [Line Items]
Number of additional shares available (in shares) | shares							200,000